Diffusion tensor analysis of pediatric multiple sclerosis and clinically isolated syndromes

American Journal of Neuroradiology

Volumn 34, Issue 2, 2013, Pages 417-423

  Vishwas, M S ^a   Healy, B C ^a   Pienaar, R ^a   Gorman, M P ^a   Grant, P E ^a   Chitnis, Tanuja ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATING DISEASE; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; MALE; MULTIPLE SCLEROSIS; SCHOOL CHILD; WHITE MATTER;

ADOLESCENT; ANISOTROPY; CHILD; CHILD, PRESCHOOL; DIFFUSION TENSOR IMAGING; DISEASE PROGRESSION; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FEMALE; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MULTIVARIATE ANALYSIS; NERVE FIBERS, MYELINATED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SYNDROME;

EID: 84876169760     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3216     Document Type: Article

References (29)

1. Chitnis T, Glanz B, Jaffin S, et al. Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States. Mult Scler 2009;15:627-31
2. Boiko A, Vorobeychik G, Paty D, et al. Early onset multiple sclerosis: a longitudinal study. Neurology 2002;59:1006-10
3. Ghezzi A, Deplano V, Faroni J, et al. Multiple sclerosis in childhood: clinical features of 149 cases. Mult Scler 1997;3:43-46 (Pubitemid 27234861)
4. Renoux C, Vukusic S, Mikaeloff Y, et al. Natural history of multiple sclerosis with childhood onset. N Engl J Med 2007;356:2603-13 (Pubitemid 46961005)
5. Gorman MP, Healy BC, Polgar-Turcsanyi M, et al. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009;66:54-59
6. MacAllister WS, Belman AL, Milazzo M, et al. Cognitive functioning in children and adolescents with multiple sclerosis. Neurology 2005;64:1422-25 (Pubitemid 40570512)
7. Amato MP, Goretti B, Ghezzi A, et al. Cognitive and psychosocial features of childhood and juvenile MS. Neurology 2008;70:1891-97 (Pubitemid 351684642)
8. Hahn CD, Shroff MM, Blaser SI, et al. MRI criteria for multiple sclerosis: evaluation in a pediatric cohort. Neurology 2004;62:806-08 (Pubitemid 38298964)
9. Vishwas M, Chitnis T, Pienaar R, et al. Tract-based analysis of callosal, projection and association pathways in pediatric patients with multiple sclerosis: a preliminary study. AJNR Am J Neuroradiol 2010;31:121-28
10. Mikaeloff Y, Suissa S, Vallee L, et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004;144:246-52 (Pubitemid 38869403)
11. Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004;127:1942-47 (Pubitemid 39150253)
12. Neuteboom RF, Boon M, Catsman Berrevoets CE, et al. Prognostic factors after a first attack of inflammatory CNS demyelination in children. Neurology 2008;71:967-73
13. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 2007;68:S7-12
14. Mori S, van Zijl PC. Fiber tracking: principles and strategies - a technical review. NMR Biomed 2002;15:468-80 (Pubitemid 36054510)
15. Wakana S, Jiang H, Nagae-Poetscher LM, et al. Fiber tract-based atlas of human white matter anatomy. Radiology 2004;230:77-87 (Pubitemid 37549786)
16. Catani M, Howard RJ, Pajevic S, et al. Virtual in vivo interactive dissection of white matter fasciculi in the human brain. Neuroimage 2002;17:77-94
17. Catani M, Thiebaut de Schotten M. A diffusion tensor imaging tractography atlas for virtual in vivo dissections. Cortex 2008;44:1105-32
18. Bester M, Heesen C, Schippling S, et al. Early anisotropy changes in the corpus callosum of patients with optic neuritis. Neuroradiology 2008;50:549-57
19. Yu CS, Lin FC, Liu Y, et al. Histogram analysis of diffusion measures in clinically isolated syndromes and relapsing-remitting multiple sclerosis. Eur J Radiol 2008;68:328-34
20. Caramia F, Pantano P, Di Legge S, et al. A longitudinal study of MR diffusion changes in normal appearing white matter of patients with early multiple sclerosis. Magn Reson Imaging 2002;20:383-88 (Pubitemid 35006892)
21. Werring DJ, Clark CA, Barker GJ, et al. Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology 1999;52:1626-32 (Pubitemid 29220638)
22. Cercignani M, Inglese M, Pagani E, et al. Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol 2001;22:952-58 (Pubitemid 32436241)
23. Hasan KM, Gupta RK, Santos RM, et al. Diffusion tensor fractional anisotropy of the normal-appearing seven segments of the corpus callosum in healthy adults and relapsing-remitting multiple sclerosis patients. J Magn Reson Imaging 2005;21:735-43 (Pubitemid 40770865)
24. Inglese M, Salvi F, Iannucci G, et al. Magnetization transfer and diffusion tensor MR imaging of acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2002;23:267-72 (Pubitemid 34160433)
25. Vrenken H, Seewann A, Knol DL, et al. Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types. AJNR Am J Neuroradiol 2010;31:541-48
26. Rocca MA, Absinta M, Moiola L, et al. Functional and structural connectivity of the motor network in pediatric and adult-onset relapsing-remitting multiple sclerosis. Radiology 2010;254:541-50
27. Chitnis T, Pirko I. Sensitivity vs specificity: progress and pitfalls in defining MRI criteria for pediatric MS. Neurology 2009;72:952-53
28. Kappos L, Freedman MS, Polman CH, et al. Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study. Lancet 2007;370:389-97 (Pubitemid 47189673)
29. Kinkel RP, Kollman C, O'Connor P, et al. IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology 2006;66:678-84 (Pubitemid 43739821)